Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancies

被引：0
|
作者：
Rejeski, K. [1 ,2 ,3 ]
Tebaldi, T. [1 ]
Joshi, P. [1 ]
Liang, Y. [1 ]
Pfeifer, D. [2 ]
Luebbert, M. [2 ]
Halene, S. [1 ]
机构：
[1] Yale Univ, Sch Med, Sect Hematol, Yale Canc Ctr, New Haven, CT USA
[2] Univ Klinikum Freiburg, Med Klin 1, Onkol & Stammzelltransplantat, Freiburg, Germany
[3] LMU Grosshadern, Med Klin 3, Hamatol & Onkol, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V540
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [11] SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
    Amandeep Aujla
    Katherine Linder
    Chaitanya Iragavarapu
    Michael Karass
    Delong Liu
    Biomarker Research, 6
  • [12] SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
    Aujla, Amandeep
    Linder, Katherine
    Iragavarapu, Chaitanya
    Karass, Michael
    Liu, Delong
    BIOMARKER RESEARCH, 2018, 6
  • [13] Biological Analysis of SRSF2 Mutations in Leukemogenesis
    Matsunawa, Manabu
    Sanada, Masashi
    Yamamoto, Ryo
    Yoshida, Kenichi
    Nagata, Yasunobu
    Kon, Ayana
    Yoshizato, Tetsuichi
    Otsu, Makoto
    Nakauchi, Hiromitsu
    Ogawa, Seishi
    BLOOD, 2012, 120 (21)
  • [14] Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations
    Tashakori, Mehrnoosh
    Khoury, Joseph D.
    Routbort, Mark J.
    Patel, Keyur P.
    Wang, Sa A.
    Ok, Chi Young
    El-Hussein, Siba
    Kanagal-Shamanna, Rashmi
    Luthra, Rajyalakshmi
    Hu, Shimin
    Lin, Pei
    Pemmaraju, Naveen
    Bose, Prithviraj
    Verstovsek, Srdan
    Bueso-Ramos, Carlos E.
    Medeiros, L. Jeffrey
    Loghavi, Sanam
    MODERN PATHOLOGY, 2022, 35 (11) : 1677 - 1683
  • [15] Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrow
    Mori, Minako
    Sakai, Tomomi
    Oka, Tomomi
    Sakurada, Maki
    Iwasaki, Makoto
    Takeda, June
    Kanda, Junya
    Nannya, Yasuhito
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    Moriyoshi, Koki
    Kawabata, Hiroshi
    BRITISH JOURNAL OF HAEMATOLOGY, 2025,
  • [16] CTX-712, a novel CLK inhibitor targeting myeloid neoplasms with SRSF2 mutation
    Yoda, Akinori
    Morishita, Daisuke
    Mizutani, Akio
    Ochi, Yotaro
    Tozaki, Hirokazu
    Satoh, Yoshihiko
    Takeda, June
    Nannya, Yasuhito
    Makishima, Hideki
    Miyake, Hiroshi
    Ogawa, Seishi
    CANCER SCIENCE, 2021, 112 : 250 - 250
  • [17] CTX-712, a novel CLK inhibitor targeting myeloid neoplasms with SRSF2 mutation
    Yoda, Akinori
    Morishita, Daisuke
    Ochi, Yotaro
    Mizutani, Akio
    Takeda, June
    Tozaki, Hirokazu
    Satoh, Yoshihiko
    Nannya, Yasuhito
    Makishima, Hideki
    Miyake, Hiroshi
    Ogawa, Seishi
    CANCER SCIENCE, 2022, 113 : 869 - 869
  • [18] SRSF2 mutations worsen prognosis of myeloproliferative syndromes
    Chauveau, Aurelie
    HEMATOLOGIE, 2013, 19 (02): : 90 - 91
  • [19] Exploring the Molecular Grey Zone of Myeloid Neoplasms: Concurrent SRSF2 and Classic MPN Driver Mutations
    Tashakori, Mehrnoosh
    Khoury, Joseph
    Routbort, Mark
    Patel, Keyur
    Wang, Sa
    Ok, Chi Young
    Kanagal-Shamanna, Rashmi
    Luthra, Rajyalakshmi
    Hu, Shimin
    Khanlari, Mahsa
    El Hussein, Siba
    Lin, Pei
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Loghavi, Sanam
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1395 - 1396
  • [20] Molecular landscape and clinical outcome of SRSF2/TET2 Co-mutated myeloid neoplasms
    Cockey, Samuel G.
    Zhang, Hailing
    Hussaini, Mohammed
    Zhang, Ling
    Moscinski, Lynn
    Yang, Ethan
    Li, Julie
    Wang, Le
    Song, Jinming
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 469 - 478
12345